Close navigation

What we're funding

We are the leading funder of brain tumour research in the UK, committing over £50 million to date on pioneering projects that will help adults and children with brain tumours.

We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.

Our latest research grants

We're pleased to share our most recent research awards. Our Scientific Advisory Board told us that these are the highest quality grants with the best chance of success. We look forward to seeing their progress in the coming months and years.

Dr Gelareh Zadeh

Liquid biomarkers to change meningioma care

Dr Gelareh Zadeh

Liquid biomarkers to change meningioma treatment

This project is advancing research into how aggressive meningiomas can be diagnosed and how their treatment responses can be predicted. In collaboration with a major UK-led clinical trial and using advanced artificial intelligence, the team are striving towards tomorrow’s clinical care.


Find out more

Professor Sebastian Brandner

Nanoparticle Couriers for GBM treatments

Professor Sebastian Brandner

Nanoparticle couriers for GBM treatments

When it comes to glioblastoma (GBM) treatments, there two key challenges: effective treatments and how to deliver them across the blood brain barrier. This grant has a fresh approach to both. Professor Brandner’s team are testing whether microRNAs can stop tumour growth when delivered by nanoparticles.

Dr Rameen Beroukhim

Investigating transcription factors in development

Dr Rameen Beroukhim

Investigating transcription factors in development

Dr Beroukhim’s team are doing an in-depth analysis of two transcription factors, one that they suspect drives low grade brain tumours and the other that may drive high grade brain tumours.

Ultimately they’ll be looking for ways to use drugs to return transcription to normal levels, and stop tumour growth.

Professor Louis Chesler

The SRC protein in children's glioma

Professor Louis Chesler

Targeting SRC in childhood glioma

One of our ongoing grants identified a protein called SRC that may be driving group 4 medulloblastomas in children. This type of tumour has been notoriously difficult to study and to treat. This new research will delve into the role of SRC in starting and motivating tumour growth, and the team will be using sophisticated lab models to test a new drug to target it.

Dr Philipp Euskirchen

Working towards a faster diagnosis

Dr Philipp Euskirchen

Working towards a faster diagnosis

Molecular biomarker testing is becoming routine for people with brain tumours because it provides clinicians with a clearer path to the best available treatment. This project aims to decrease the time it takes to get the tests done, meaning that people have faster diagnoses and start on the best treatments sooner.

Research projects

As part of our research strategy, A Cure Can't Wait, we have established various funding opportunities to achieve our goals of doubling survival and halving the harm caused by a brain tumour. More information about the different types of grants we fund can be found below:

Child brain tumour research

Current and past research projects to enhance our understanding of tumours and how to treat them

Learn more

Adult brain tumour research

Read about our current and past research projects, furthering our understanding of adult brain tumours and treatments

Learn more